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Stable isotope labeling is a generally applicable method of
quantifying cell dynamics. Its advent has opened up the way
for the quantitative study of T cells in humans. However, the
literature is confusing as estimates vary by orders of magni-
tude between studies. In this short review we aim to explain the
reasons for the discrepancies in estimates, clarify which esti-
mates have been superseded and why and highlight the cur-
rent best estimates. We focus on stable isotope labeling of T
cell subsets in healthy humans.
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model.Introduction
Recent advances in our understanding of human T
cell kinetics have resulted from concurrent develop-
ment of experimental and theoretical approaches.
Experimentally, it has been difficult to find a meth-
odology that reliably reports in vivo T cell kinetics.
The earliest studies used the rate of loss of thera-
peutic X rayeinduced chromosome changes in pa-
tients with ankylosing spondylitis [1] or cancer [2,3].
However, this method is only applicable to patients
receiving radiotherapy and assumes that radiation
damage does not impact cell lifespan. The nextwww.sciencedirect.comgeneration of quantitative studies in humans utilised
the thymidine analogue bromodeoxyuridine (BrdU)
[4] but this too was beset with difficulties, both
ethical (BrdU is not without toxicities) and theo-
retical (BrdU incorporation in DNA may itself per-
turb cell lifespan [5,6]). The field was revolutionised
in the 1990s by the advent of stable isotope labeling
[7e10]. Stable isotopes such as deuterium (2H) are
thought to be nontoxic and to have no impact on cell
lifespan at the tracer doses used [5,11]. The premise
of this approach is that DNA synthesis is a surrogate
for cell replication, that the cellular content of DNA
is fixed and that nonreplicative DNA synthesis is
negligible.
A cursory read of the stable isotope labeling literature
can be confusing as the estimated kinetics (prolifera-
tion, generation, disappearance rates) of the various T
cell subpopulations vary from one study to the next.
This is in part due to evolving phenotypic definitions of
T cell subsets, in part due to evolving modeling tech-
niques and in part due to differences in nomenclature
for the key parameters; even given these explanations
some of the discrepancy remains unexplained. Here we
review the quantification of T cell subpopulations with
the aim of explaining the source of some of these dif-
ferences between estimates, highlighting the current
best estimates. We restrict ourselves to Tcells in healthy
humans.Stable isotope labeling: an overview
We start with a very brief overview of the stable
isotope labeling method and then consider some of
the important points in more detail later. A typical
protocol for quantifying cell dynamics in vivo starts
with the administration of the stable isotope label
into a DNA precursor metabolite, typically either
heavy water (2H2O) or deuterium-labeled glucose
(6,6-2H2-glucose) [5,12]. Blood is sampled at regular
time intervals, the cell populations of interest are
sorted by fluorescence-activated cell sorting (FACS)
and the fraction of labeled deoxyribose in their DNA
is quantified by mass spectrometry. Label is gained
when cells proliferate and lost when the labeled cell
dies, differentiates to another phenotype or exits the
blood compartment long-term. The time course of
the fraction of labeled DNA thus contains informa-
tion about cell proliferation and cell disappearance.
To extract this information, mathematical models areCurrent Opinion in Systems Biology 2019, 18:77–86
78 Systems immunology & host-pathogen interactionconstructed to describe the process and fitted to the
experimental data. This permits the quantification of
the rate of proliferation of any cell population that
can be sampled and sorted in sufficient quantity in
humans in vivo.
Two important considerations in labeling studies are (i)
duration of labeling and (ii) data normalisation, both of
which are closely related to the choice of label. For
glucose, since the body pool is small and dynamic, 2H2-
glucose enrichments peak quickly so labeling periods
can be very short (bolus, 10 h, 24 h and 7 day durations
have been used [13e15]). In contrast, because the body
water pool is large, 2H2O labeling takes weeks. The
lifespan of the cells of interest determines the optimal
labeling period; ideally the target cell population should
show considerable but not 100% replacement during the
labeling period so that the signal is measurable but not
saturated. Consequently, 2H2-glucose is good for rapidly
dividing cells and D2O is better suited to slowly dividing
populations.
In terms of normalisation, isotope labeling requires two
normalisation steps: one to adjust for label availability in
the individual (determined by dose, timing and dilution
by unlabeled glucose/water), and one to scale between
label in the plasma and the resulting label in DNA. For
both water and glucose protocols, label availability in the
plasma/body water is measured at multiple time-points
and an empirical curve fitted to describe the enrich-
ment, usually a square pulse with exponential tail for
2H2-glucose and a logistic growth/exponential decay
curve for 2H2O. The second normalisation step is the
scaling parameter (referred to as c, or bw for
2H2O la-
beling and b or bg for
2H2-glucose labeling); this is the
ratio between label enrichment in newly synthesised
DNA and that in plasma. In vitro 2H2-glucose labeling
experiments show that enrichment levels in DNA
plateau at about 60e75% of media enrichment [11,12].
This has been attributed to intracellular dilution by
unlabeled preformed deoxynucleotide triphosphates
and by other pentose precursors [11]. For 2H2O the
scaling factor can be determined within the individual
by sampling cells such as monocytes or granulocytes that
can be expected to be fully replaced within the labeling
period. By estimating their plateau enrichment, the
scaling between DNA enrichment and plasma enrich-
ment can be calculated. Deoxyribose contains seven
nonexchangeable hydrogen atoms, any of which might
potentially be replaced by deuterium in a D2O labeling
study. Consequently, the enrichment seen in deoxyri-
bose exceeds that seen in plasma. The scaling has a
binomial dependence on label availability in the plasma
(any of the sites can be labeled or not labeled with
probability dependent on plasma label enrichment). It
can be shown that when n = 7 then, for the plasma
enrichments typically attained, the scaling factor would
be expected to lie in the range 6.18-6.68 (not 7 asCurrent Opinion in Systems Biology 2019, 18:77–86sometimes erroneously stated) [7]. Empirically the
scaling factor is observed to lie in the range 3.2e5.2
[14,16]; why there is variation between individuals in
what might be expected to be a basic biochemical
parameter and why the observed range differs from the
theoretically expected range is unclear and indicates
that there may be errors in the calculation of this
parameter. Label enrichment in DNA is directly pro-
portional both to the scaling factor and to the prolifer-
ation rate (Supplementary Information) so an error in
the scaling factor will cause the inverse error in the
proliferation rate (if b is erroneously estimated to be
double the true value, the proliferation rate estimated
will be half the true value).
T cell dynamics: what we have learnt
We focus on CD8þ T cells in the text and Table 1;
analogous numbers for CD4þ T cells are provided in
Table 2.
Naïve CD8þ T cells. Thymic output and peripheral
proliferation both contribute to maintenance of the
naı¨ve T cell pool. Since the isotope will label any
proliferating cell, no distinction can be made between
cells that divided in the periphery and cells that ac-
quired label in the thymus and then entered the pe-
riphery [17]. Most models to describe naı¨ve cell
dynamics ignore thymic output and attribute all label
accrual to naı¨ve cell proliferation; this will tend to lead
to an overestimate of proliferation rates and an under-
estimate of disappearance rates (Box 1). This caveat
aside, the first study to investigate naı¨ve T cells using
isotope labeling found a median naı¨ve CD8þ T cell
proliferation rate of p = 0.002 d1 (corresponding to a
doubling time of ln(2)/0.002 = 295 days) [13], Tables 1
and 2. A later study found a considerably slower prolif-
eration rate (p = 0.0003 d1, doubling time = 2300
days) [16]. Part of this difference can be explained by
the problem of evolving phenotypic definitions. Both
studies inadvertently included what we would now call
non-naı¨ve cells in their sorted “naı¨ve” populations
(defined as CD45RAþ and CD45ROdCD27þ, respec-
tively). This would have included terminally differen-
tiated effectors (TEMRA) in the first study and stem cell
memory Tcells (TSCM) in the second (neither of which
had been described at the time). A study using the most
recent definition (CD45ROdCD27brightCCR7þCD95d)
finds that naı¨ve CD8þ Tcells have a proliferation rate of
0.0005 d1 (doubling time = 1400 days) [18]. By
including an analysis of T cell receptor excision circles
(TRECs), a further study split naı¨ve CD4þ T cell pro-
duction into cells arising from the thymus and cells
arising from peripheral proliferation. It was shown that
in adult humans, in stark contrast to mice, the over-
whelming majority of new naı¨ve CD4þ cells (approx.
100%) arose from peripheral division [19]. This fasci-
nating result illustrates the importance of studying
humans wherever possible. Unfortunately, althoughwww.sciencedirect.com
Table 1
Summary of estimates of CD8+ T cell generation and proliferation rates in humans.
Population Phenotype Generation rate
(d−1)
Range (d−1) Proliferation
rate (d−1)
Range (d−1) Source Method Notes
Naïve CD45RA+ 0.002 [100% self-
renewal, 0% from
thymus [19]]
0.0–0.01 0.002 0.0–0.01 Macallan et al. [13] Table 1
a
1d 2H2-glu kh model Based on best phenotypic
definition at time. Will
inadvertently have included
TEMRA and TSCM.
CD45ROdCD27+ 0.0003 0.0003–0.0005 0.0003 0.0003–0.0005 Vrisekoop et al. [16] Table 1
a
63d 2H2O kh model Based on best phenotypic
definition at time. Will
inadvertently have included
TSCM.
CD45ROdCD27brightCCR7+CD95d 0.00045 0.0003–0.0006 0.00045 0.0003–0.0006 Costa del Amo et al. [18]
Table S2 a
49d 2H2O precursor
model
TSCM CD45RO
dCD27brightCCR7+CD95+ 0.01 [64% self-
renewal, 35%
from naïve pool
[18]]
0.006–0.07 0.007 0.002–0.01 Costa del Amo et al. [18]
Table 1 and S2 (see
notes)
49d 2H2O precursor
model
Paper found evidence for  two
subpopulations. Here we
report the average rates
derived from Table 1 (ratio of
subpopulations) and
Table S2 (proliferation and
disappearance of
subpopulations)
Memory CD45RAd 0.019 0.006–0.16 Macallan et al. [13] Table 1¥ 1 d 2H2-glu kh model Later corrected by Ahmed et al.
see below
CD45RO+ 0.0028 0.0019–0.006 Vrisekoop et al. [16]
Table 1¥
63d 2H2O kh model Later corrected by Westera et al.
and Ahmed et al. see below
CD45RO+ 0.006 0.004–0.009 Westera et al. [27] in line text
(note typo on upper limit
of range in original paper,
corrected here)¥
63d 2H2O multi-exp
model
Corrected analysis of Vrisekoop
et al. data
CD45RAd 0.015 0.006–0.11 Ahmed et al. [28] adjustment
taken from Table S1 and
applied to Macallan
estimates¥
1d 2H2-glu kh model Corrected analysis of Macallan
et al. data.
CD45RO+ 0.007 0.004–0.009 Ahmed et al. [28] adjustment
taken from Figure S7
(ratio of bw) and applied to
Westera estimates ¥
63d 2H2O multi-exp
model
Further corrected analysis of
Vrisekoop et al. data.
Estimates (within each subpopulation) provided in chronological order. Estimates shown in bold font are current best estimates, estimates in regular font have been superseded (see final column, notes). All
estimates, with the exception of the TSCM subpopulation parameters, assume there is no input from a precursor population (Box 1). Work from Westera et al. indicates this is a valid assumption for naïve cells.
However, for memory cells we cannot necessarily neglect input from the precursor population (in this case naïve cells). Proliferation rate estimates marked ¥ may therefore need to be revised when additional
data are available.
All rates provided as proportion of target cell population and represent the median across study individuals.
Abbreviations: D2-glu: D2-glucose, kh model: kinetic heterogeneity model, multi-exp model: multi-exponential model.
Model equations provided in Supplementary Information.
The range is the minimum and maximum value of the point estimate observed across the subjects.
a Proliferation rate estimate for naïve cells calculated from production rate based on the finding that 100% of new naïve cells in humans originate from peripheral proliferation [19].
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Table 2
Summary of estimates of CD4+ T cell generation and proliferation rates in humans.
Population Phenotype Generation rate
(d−1)
Range (d−1) Proliferation rate
(d−1)
Range (d−1) Source Method Notes
Naïve CD45RA+ 0.004 0.002–0.015 0.004 0.002–0.015 Macallan et al. [13] Table 1 a 1d 2H2-glu kh model Based on best phenotypic
definition at time. Will
inadvertently have included
TSCM.
CD45RO−CD27+ 0.0005 0.0003–0.0009 0.0005 0.0003–0.0009 Vrisekoop et al. [16] Table 1.a 63d 2H2O kh model Based on best phenotypic
definition at time. Will
inadvertently have included
TSCM.
CD45ROdCD27brightCCR7+CD95d 0.0007 0.0004–0.001 0.0007 0.0004–0.001 Costa del Amo et al. unpub. 49d 2H2O precursor model
TSCM CD45RO
dCD27brightCCR7+CD95+ NA NA NA NA Parameters not estimated for
CD4+ TSCM due to lack of
additional data (YFV)
Memory CD45RAd 0.02 0.01–0.08 Macallan et al. [13] Table 1¥ 1d 2H2-glu kh model Later corrected by Ahmed et al.
see below
CD45RO+ 0.0045 0.002–0.007 Vrisekoop et al. [16] Table 1¥ 63d 2H2O kh model Later corrected by Westera et al.
and Ahmed et al. see below
CD45RO+ 0.0061 0.002–0.01 Westera et al. in line text [27]¥ 63d 2H2O multi-exp model Corrected analysis of Vrisekoop
et al. data
CD45RAd 0.018 0.009–0.05 Ahmed et al. [28] adjustment
taken from Table S1 and
applied to Macallan
estimates¥
1d 2H2-glu kh model Corrected analysis of Macallan
et al. data.
CD45RO+ 0.0064 0.002–0.01 Ahmed et al. [28] adjustment
taken from Figure S7 (ratio of
bw) and applied to Westera
estimates ¥
63d 2H2O Multi-exp model Further corrected analysis of
Vrisekoop et al. data.
Central
memory
CD45RO+CCR7+ 0.010 0.007–0.04 Macallan et al. [43] Table 2¥ 1d 2H2-glu kh model
Effector
memory
CD45RO+CCR7- 0.042 0.02–0.08 Macallan et al. [43] Table 2¥ 1d 2H2-glu kh model
Estimates (within each subpopulation) provided in chronological order. Estimates shown in bold font are current best estimates, estimates in regular font have been superseded (see final column, notes). All
estimates assume there is no input from a precursor population (Box 1). Work from Westera et al. indicates this is a valid assumption for naïve cells. However, for memory cells we cannot necessarily neglect
input from the precursor population (in this case naïve cells). Proliferation rate estimates marked ¥ may therefore need to be revised when additional data are available.
The range is the minimum and maximum value of the point estimate observed across the subjects.
All rates provided as proportion of target cell population and represent the median across study individuals.
Abbreviations: D2-glu: D2-glucose, kh model: kinetic heterogeneity model, multi-exp model: multi-exponential model.
Model equations provided in Supplementary Information.
a Proliferation rate estimate for naïve cells calculated from production rate based on the finding that 100% of new naïve cells in humans originate from peripheral proliferation [19].
80
S
ystem
s
im
m
u
n
o
lo
g
y
&
h
o
st-p
ath
o
g
en
in
teractio
n
C
u
rren
t
O
p
in
io
n
in
S
ystem
s
B
io
lo
g
y
2019,
18:77
–
86
w
w
w
.sciencedirect.com
Box 1. Nomenclature: generation, proliferation, disappearance, turnover and half-lives.
For a target population in equilibrium (i.e. at steady state), the generation of new cells (at rate g) either by influx from a precursor (progenitor)
population at rate i and/or proliferation (i.e. self-renewal) at rate p, is balanced by cell disappearance (death, differentiation, long-term exit from
blood, at rate d) such that g=i+p=d. With a few exceptions [14,18,24,45], the majority of labeling studies ignore the influx from precursor
populations (i.e. i is assumed to be zero) and all label accrual is attributed to self-renewal. The impact of this assumption on the rates estimated
will depend on both the kinetics and size of the precursor population compared with the target population; the impact of including an upstream
compartment has been demonstrated explicitly for neutrophils [14], CD4+memory T cells [24] and CD4+ and CD8+ TSCM cells (unpublished work).
The expansion of models to include a nonzero influx term means that two widely used terms in cell kinetics, turnover and half-life, which were
previously precisely defined, are now ambiguous. A number of studies report the “turnover rate” of a population which is either the proliferation
rate or the disappearance rate. When the influx from the precursor population is assumed to be zero then, for a population at steady state, the
proliferation rate equals the disappearance rate and the turnover rate is unambiguously defined. However, when the influx is nonzero, the
definition of “turnover” is unclear and we avoid its use in this review. Similarly for the population half-life. With zero influx the half-life (time for the
population to halve in size if there was no proliferation) = ln(2)/p = ln(2)/d. However, if nonzero influx is considered, then another parameter can be
defined, the “clonal half-life”, ln(2)/(d-p). The clonal half-life is the time for a T cell clone to halve in size whilst the overall population remains at
steady state (i.e. without halting proliferation) and likely relates to the longevity of a T cell clone (for zero influx the clonal half-life is infinite). Models
describing an upstream/precursor population and a downstream/target cell population were used by Costa del Amo et al. to describe the rela-
tionship between naïve and TSCM cells [18]; the equations are given in Supplementary Information.
This input from a precursor population considered earlier is distinct from the “source” term included in early models of labeling dynamics [46,47].
In these early models the target cell population was assumed to be homogeneous and the source was invoked to explain the observation that the
measured disappearance rate typically exceeded the measured proliferation rate despite the fact that the target cell population was of approx-
imately constant size over time. However, the size and nature of the source in these models (typically large and unlabeled) meant it was usually
not possible to find a physiological correlate of the source. Instead it was proposed that the discrepancy between the measured proliferation and
disappearance rates could be explained by kinetic heterogeneity in the population [17]. That is, if the target population is heterogeneous, then
although the measured proliferation rate will be the average proliferation rate of the population the loss of labeled cells will be biased towards the
rapidly turning over subpopulation and will therefore overestimate the average disappearance rate of the whole population.
Definitions
Proliferation p
Disappearance d
Doubling Time ln(2)/p
Half-life ln(2)/d
Clonal half-life ln(2)/(d-p)
Lifespan 1/d
The above-mentioned definitions are correct under the assumption that times to proliferate and disappear are exponentially distributed.
Current Estimates of T Cell Kinetics in Humans Macallan et al. 81TSCM cells had been described by this point, the anal-
ysis used an older definition of naı¨ve T cells
(CD45ROdCD27þ) which would have included TSCM
cells. True naı¨ve cells have lower proliferation and much
higher TREC content than TSCM cells [18,20,21]; thus
a large proportion of peripheral proliferation, which was
attributed to naı¨ve cells in this study, may in fact be due
to TSCM cells. Moreover, TSCM cells are a considerably
more frequent population in humans than mice and sowww.sciencedirect.comthe failure to exclude TSCM cells from the naı¨ve cell gate
may partly explain why more replacement by prolifera-
tion was seen in humans than mice [20,22]. It would be
interesting to redo this important analysis delineating
the contribution of true naı¨ve cells and TSCM cells. It
seems likely that the inclusion of TSCM cells could
explain some but not all of the reported difference be-
tween mice and humans in the contribution of thymic
output.Current Opinion in Systems Biology 2019, 18:77–86
82 Systems immunology & host-pathogen interactionStem cell memory T cells (TSCM). TSCM cells are a
recently described subpopulation of T cells with stem
cellelike properties of self-renewal, clonal longevity and
multipotency. It is postulated that they are responsible
for maintaining long-lived immune memory [20]. Until
2018, self-renewal and longevity of human TSCM cells
had only been demonstrated in vitro. Using a combina-
tion of mathematical modeling, stable isotope labeling,
telomere length analysis and data from vaccinees, it was
possible to quantify the self-renewal, proliferation and
clonal longevity of TSCM cells in humans in vivo. Unex-
pectedly, it was found that the average lifespan of a
TSCM clone is short (clonal half-life < 1 year, prolifera-
tion rate = 0.007 d1), far too short to maintain immune
memory that can last for decades. However, it was also
shown that what we currently define as the TSCM pop-
ulation (CD45ROdCD27brightCCR7þCD95þ [23])
comprises at least two kinetically distinct sub-
populations. One is rapidly replaced (clonal half-life
ln(2)/(d-p) = 5 months) which explains the short
average lifespan of the bulk TSCM population, and the
other having a clonal half-life of approximately 9 years,
consistent with the longevity of immune memory. This
long-lived subpopulation had a high degree of self-
renewal, with a cell residing without dying or differen-
tiating for 15% of our lifetime. It was postulated that
this subpopulation represents the “true” stem cellelike
population (the other subpopulation may represent cells
transiting to effector status). Interestingly, in apparently
healthy asymptomatic individuals, there was ongoing
differentiation of naı¨ve cells; the contribution of naı¨ve
cells to TSCM replacement was typically about 50% and
never less than 10% (i.e. 10e50% of new TSCM cells are
produced by differentiating naı¨ve cells and 50e90% by
division of existing TSCM cells). Considerable recruit-
ment of naı¨ve cells to the memory pool in the apparent
absence of novel antigen has previously been reported
for mice [24,25]. To the best of our knowledge this is the
first time this surprising observation has been made in
humans, and it is important to confirm it using an in-
dependent approach.
Memory T cells. Only one stable isotope labeling study
of CD8þ T cell memory subpopulations (central
memory and effector memory) has been carried out
[26]. In this study, sampling was restricted to long after
the end of labeling, and thus only quantifies the net loss
of labeled cells and does not permit the separation of
proliferation and disappearance. It is necessary to
sample both the uptake and the loss of label to obtain a
representative estimate of proliferation [17]. To date
this has only been performed for bulk (CD45ROþ or
CD45RA) CD8þ memory Tcells (though some CD4þ
memory subsets have been studied, Table 2). The first
such study, which used a 24 h 2H2-glucose labeling
protocol, found that memory CD8þ Tcells proliferated
rapidly (p = 0.019 d1, doubling time = 36 days). A
subsequent study, utilising a 63 d D2O protocol, foundCurrent Opinion in Systems Biology 2019, 18:77–86considerably slower proliferation (p = 0.0028 d1,
doubling time = 248 days).
Investigation of this discrepancy by a collaboration be-
tween the two groups involved [27,28] has highlighted
some critical factors in analysing isotope labeling data.
Firstly, in long labeling studies, saturation of sub-
populations must be accounted for. Adjusting for satu-
ration in the 63-day 2H2O study led to revised estimates
of p = 0.006 d1 (doubling time = 116 days). Whether
saturation has occurred can be investigated by
comparing the fits of models with increasing numbers of
subpopulations and checking for a change in the esti-
mated average proliferation rate [27,29]. Secondly,
normalisation is critical, particularly for overnight 2H2-
glucose labeling. We postulated that errors may arise
from reduced plasma glucose sampling overnight when
unlabeled glucose influx (food) is reduced; periods of
higher glucose enrichment may thus be missed. A pre-
diction of this postulate (that monocytes would have
plateau label of >100%) was borne out. Correcting for
these inaccuracies in normalisation decreased prolifera-
tion rate estimates made using D2-glucose (to p=0.015
d-1) and increased estimates made using D2O (to
p=0.007 d-1). A more sophisticated approach in which
plasma glucose was predicted rather than measured
came to very similar conclusions [30]. The estimates
from the two studies are now closer together, but there
does still appear to be some genuine, unresolved dif-
ference. Current best estimates of the proliferation rate
of memory CD8þ T cells are therefore in the range
0.007-0.015 d1 (corresponding to a doubling time of
between 46 and 99 days).
It is interesting that these studies show that more highly
differentiated T cells have more rapid proliferation
(Fig. 1; see also CD4þ subpopulations Table 2) despite
the decrease in proliferative potential that is thought to
be associated with differentiation [23,31] and the
prevalent view that cell senescence is linked with poor
proliferation [32e34].
Modeling considerations
Mathematical models of T cell kinetics necessarily
involve assumptions, firstly because we do not
completely understand the biology (e.g. kinetic sub-
structure of T cell populations [17,24], the lineage
relationship between T cell subpopulations [35], the
rules determining cell fate [36e38]) but secondly, more
importantly, even if the biology was completely known,
it would still be essential to simplify models for
parameter inference (if models are overly complex
compared with the data, the parameters cannot be
estimated). And so mathematical models of T cell dy-
namics for parameter inference will always contain as-
sumptions. This means that estimates from isotope
labeling are necessarily susceptible to model assump-
tions. This problem was starkly illustrated by a recentwww.sciencedirect.com
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Estimates of CD8+ T cell proliferation rates as a function of cell differentiation state.a. Current best estimates of the proliferation rates for different
CD8+ T cell subsets in healthy adult humans (Table 1). Naïve T cells. Estimates from Costa del Amo et al. [18]. TSCM cells. Estimates from Costa del
Amo et al. [18]. Memory T cells. Estimates from Macallan et al. adjusted by Ahmed et al. [13,28]. Memory T cells. Estimate from Vrisekoop et al.
adjusted by Westera et al., further adjusted by Ahmed et al. [16,28,44].b Cartoon of proliferation rate as a function of differentiation state. All the evidence
indicates that naïve T cells proliferate more slowly than TSCM cells and memory T cells, i.e. estimated T cell proliferation increases with differentiation
despite the decrease in proliferative potential that is thought to be associated with differentiation [23,31,32].
Current Estimates of T Cell Kinetics in Humans Macallan et al. 83debate over the lifespan of neutrophils. In 2012, a paper
by Pillay et al. utilising isotope labeling found that, far
from being a very short-lived population as previously
thought, blood neutrophils had lifespans of about 5 days,
at least 10 times longer than previous estimates [39, 40].www.sciencedirect.comIf correct, the work by Pillay et al. would have over-
turned two decades of research. However, a subsequent
response proposed that the unexpectedly long lifespans
from the labeling study could result from data misin-
terpretation [41]. This was later confirmed by Lahoz-Current Opinion in Systems Biology 2019, 18:77–86
84 Systems immunology & host-pathogen interactionBeneytez et al. who combined a reanalysis of the data
from Pillay et al. as well as generation of new labeling
data to show that the 2012 labeling study had included
an implicit unphysiological assumption. Lahoz-
Beneytez et al. showed that by neglecting the fact
that neutrophils are produced by proliferation outside of
the observed compartment (i.e. are produced by
proliferating precursors in the bone marrow rather than
by proliferation of neutrophils in the blood), Pillay et al.
had essentially assumed the ratio of blood neutrophils to
the bone marrow neutrophil precursor mitotic pool was
infinite, leading to a severe underestimate of the
neutrophil death rate [14]. Using a more physiological
model, Lahoz-Beneytez et al. found the best estimate of
neutrophil half-life lay in the range 13e19 h, consistent
with the traditional dogma that blood neutrophils are
short-lived. More generally, neglecting the upstream
compartment will affect kinetic estimates of all cell
populations (Box 1). Proliferation rates of memory T
cells (currently estimated without allowing for input
from the naı¨ve Tcell compartment) are also susceptible
to such error and may need to be revised once more data
are available [18,24].Future directions
There are a number of areas that are ripe for devel-
opment. The first area where more research is essential
is robustness of parameter estimates to model as-
sumptions. Personally, we routinely examine the impact
of assumptions that we are conscious of making (e.g.
neglecting recirculation) on our parameter estimates,
but this approach is very limited and ad hoc. The
problem is compounded because only a few groups
work on isotope labeling data and we collaborate closely
so there is a lack of independent criticism that comes
from having many researchers working independently
on the same problem. One way forward may be to use
the ideas of parameter estimation from ensemble
models that are being developed in the field of climate
change modeling; e.g., Ref. [42]. Another area where
progress is lacking is the normalisation factor for D2O
labeling, c (bw): why does this vary between individuals
and why does it frequently lie outside the range that
would be theoretically expected? An error in normal-
isation will directly affect proliferation rate estimates
and, to a lesser extent disappearance rate estimates.
The field has been aware of this problem for more than
10 years yet has failed to progress. And then there are a
number of easier problems: “what is the proliferation
rate of the various CD8þ T cell subpopulations that
have yet to be studied e.g. effector memory, central
memory, TEMRA?“, “is the statement that all naı¨ve cell
replacement comes from peripheral proliferation in
humans true if we exclude TSCM cells from the naı¨ve
cell gate?“, “what happens to our current estimates of
memory T cell proliferation if we include input from
differentiating naı¨ve Tcells?” In short, there has been aCurrent Opinion in Systems Biology 2019, 18:77–86decade of considerable progress, but there are still
many fundamental questions to be answered and we
would urge the community to consider addressing
these topics.Conflict of interest statement
Nothing declared.
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